Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 661 AL 675

Mutation Screening of the CHCHD2 Gene for Alzheimer's Disease and Frontotemporal Dementia in Chinese Mainland Population

Che XQ, Zhao QH, Huang Y, Li X, Ren RJ, Chen SD, Guo QH, Wang G.

J Alzheimers Dis. 2018;61(4):1283-1288. doi: 10.3233/JAD-170692.

Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist

Athanasoulia-Kaspar AP, Popp KH, Stalla GK.

Endocr Connect. 2018 Feb;7(2):R88-R94. doi: 10.1530/EC-18-0030. Epub 2018 Jan 29.

Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study

Malek N, Weil RS, Bresner C, Lawton MA, Grosset KA, Tan M, Bajaj N, Barker RA, Burn DJ, Foltynie T, Hardy J, Wood NW, Ben-Shlomo Y, Williams NW, Grosset DG, Morris HR; PRoBaND clinical consortium.

J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.

Iron as a therapeutic target for Parkinson's disease

Moreau C, Duce JA, Rascol O, Devedjian JC, Berg D, Dexter D, Cabantchik ZI, Bush AI, Devos D; FAIRPARK-II study group.

Mov Disord. 2018 Apr;33(4):568-574. doi: 10.1002/mds.27275. Epub 2018 Jan 30.

99mTc-TRODAT-1 SPECT/CT imaging as a complementary biomarker in the diagnosis of parkinsonian syndromes

Mittal BR, Sood A, Shukla J, Vatsa R, Bhusari P, Shree R, Mehta S, Goyal M, Modi M.

Nucl Med Commun. 2018 Apr;39(4):312-318. doi: 10.1097/MNM.0000000000000802.

Oscillatory activity in the cortico-basal ganglia-thalamic neural circuits in Parkinson's disease

Singh A.

Eur J Neurosci. 2018 Oct;48(8):2869-2878. doi: 10.1111/ejn.13853. Epub 2018 Feb 8.

Tau Positron Emission Tomography Imaging in Degenerative Parkinsonisms

Lyoo CH, Cho H, Choi JY, Ryu YH, Lee MS.

J Mov Disord. 2018 Jan;11(1):1-12. doi: 10.14802/jmd.17071. Epub 2018 Jan 23.

Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds

Stefanachi A, Leonetti F, Pisani L, Catto M, Carotti A.

Molecules. 2018 Jan 27;23(2):250. doi: 10.3390/molecules23020250.

Role of proteoglycans in neuro-inflammation and central nervous system fibrosis

Heindryckx F, Li JP.

Matrix Biol. 2018 Aug;68-69:589-601. doi: 10.1016/j.matbio.2018.01.015. Epub 2018 Jan 31.

The neurobiology of impulse control disorders in Parkinson's disease: from neurotransmitters to neural networks

Vriend C.

Cell Tissue Res. 2018 Jul;373(1):327-336. doi: 10.1007/s00441-017-2771-0. Epub 2018 Jan 30.

Focal disorders of the spine with compensatory deformities: how to define them

Redaelli A, Berjano P, Aebi M.

Eur Spine J. 2018 Feb;27(Suppl 1):59-69. doi: 10.1007/s00586-018-5501-8. Epub 2018 Jan 30.

Prevalence of Nausea and Vomiting in Adults Using Ropinirole: A Systematic Review and Meta-Analysis

Kurin M, Bielefeldt K, Levinthal DJ.

Dig Dis Sci. 2018 Mar;63(3):687-693. doi: 10.1007/s10620-018-4937-3. Epub 2018 Jan 30.

Xenotopic expression of alternative electron transport enzymes in animal mitochondria and their impact in health and disease

Camargo AF, Chioda MM, Rodrigues APC, Garcia GS, McKinney EA, Jacobs HT, Oliveira MT.

Cell Biol Int. 2018 Jun;42(6):664-669. doi: 10.1002/cbin.10943. Epub 2018 Feb 23.

Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson's disease: An open prospective single institution study

Kurcova S, Bardon J, Vastik M, Vecerkova M, Frolova M, Hvizdosova L, Nevrly M, Mensikova K, Otruba P, Krahulik D, Kurca E, Sivak S, Zapletalova J, Kanovsky P.

Medicine (Baltimore). 2018 Feb;97(5):e9750. doi: 10.1097/MD.0000000000009750.

The role of glucocerebrosidase in Parkinson disease pathogenesis

Gegg ME, Schapira AHV.

FEBS J. 2018 Oct;285(19):3591-3603. doi: 10.1111/febs.14393. Epub 2018 Feb 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias